Hong Kong's Sinovac Deaths a Worrying Sign for China Reopening.

(Bloomberg) -- Data indicating the Sinovac Biotech Ltd. Covid-19 vaccine is less effective than an mRNA vaccine at preventing death in elderly people in Hong Kong is a red flag for mainland China, where infections are climbing and a vast swathe of the population is inoculated with the inactivated shot. Read more: China's Low Elderly Vaccination Rate Shows Key Vulnerability It's a concerning trend for mainland China, which hasn't approved an mRNA shot and where only half of the population aged 80 and older are fully vaccinated. The data is based on the first 5,435 deaths in the current outbreak and showed that the overall fatality rate was just 0.09% for those who had gotten two vaccine doses regardless of age. [Extracted from the article]